The 5th Oligonucleotides for CNS Summit unites a select group of industry-leading biologists, chemists, C-level executives, platform tech experts, DMPK and clinical pharmacologists, all tackling the unique challenges of CNS delivered ASOs, siRNAs, miRNAs and saRNAs. Check out the 2025 agenda:

• Unpublished insights and never-seen-before data
• Two tracked workshop day designed for chemists and biologists
• 10 new presenting companies including Denali Therapeutics, Alnylam Pharmaceuticals and Novo Nordisk
• Regulator presence from Ron Wange, a former FDA expert and author of the non-clinical guidance for oligonucleotides

Meet us at the 5th Oligonucleotides for CNS Summit ! Our specialists are excited to discuss how Creative Biolabs can help develop and optimize your project. Feel free to leave your contact information and tell us your project needs!